HC Wainwright Boosts Belite Bio (NASDAQ:BLTE) Price Target to $60.00

Belite Bio (NASDAQ:BLTE – Free Report) had its target price boosted by HC Wainwright from $59.00 to $60.00 in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Belite Bio’s FY2024 earnings at ($1.12) EPS, Q1 2025 earnings […]

Leave a Reply

Your email address will not be published.

Previous post JPMorgan Chase & Co. Trims Deere & Company (NYSE:DE) Target Price to $360.00
Next post Cabaletta Bio (NASDAQ:CABA) Price Target Cut to $15.00